CCS adapting to COVID-19 realities to support Canadians during and after the pandemic
Take action to fund take-home cancer drugs
It is estimated that 2 out of 5 Canadians are expected to develop cancer in their lifetime.
Cancer patients should not face delays or financial barriers in accessing their treatments. Unfortunately, in Ontario, many patients and their families face these obstacles when it comes to take-home cancer medications.
Tell your MPP that Ontario needs a program to cover the cost of all eligible take-home cancer drugs!
We realize that our efforts cannot even be compared to what women face when they hear the words ... ‘you have cancer.’
Great progress has been made
Some cancers, such as thyroid and testicular, have survival rates of over 90%. Other cancers, such as pancreatic, brain and esophageal, continue to have very low survival rates.